Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-17

Clinical Trial Update: Seroquel XR in Adults With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 trial of Seroquel XR in adults with schizophrenia was terminated, and the results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL XR (Quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED | Results posted: 2012-07-17